SCHEMBL4385673

SCHEMBL4385673

CCCCOC(=O)NC(CC(=O)OC)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
FAAH O00519 3/20 0.51
LMNA P02545 1/20 0.51
POLB P06746 2/20 0.46
GPR88 Q9GZN0 2/20 0.46
CTSK P43235 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HPGD P15428 1/20 0.45
TACR3 P29371 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3996623 0.92 FAAH (0.55) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL844472 0.89 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL14040614 0.89 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL1721285 0.88 FAAH (0.47) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL4096169 0.87 POLB (0.51) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL16465122 0.87 FAAH (0.49) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL27648565 0.87 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL6249904 0.86 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL6190128 0.86 FAAH (0.48) SMN1; SMN2NPC1RAB9AFAAHLMNA
SCHEMBL4651068 0.85 FAAH (0.47) SMN1; SMN2NPC1RAB9AFAAHLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121676-A1 PREPERATION AND UTILITY OF CCR5 INHIBITORS Auspex Pharmaceuticals, Inc. (US) 2009-11-25 EP disclosed
WO-2008077103-A1 PREPERATION AND UTILITY OF CCR5 INHIBITORS AUSPEX PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed
CN-101107265-A Cyclic nonapeptide amides AICURIS GMBH & CO KG (DE) 2008-01-16 CN disclosed